Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard

Background/Aims The American Association for the Study of Liver Diseases recommends ultrasound (US) screening for hepatocellular carcinoma (HCC) among cirrhotic patients, regardless of body mass index (BMI), every 6 months. We examined US sensitivity for diagnosis of HCC in obese patients. Methods L...

Full description

Bibliographic Details
Main Authors: Jamak Modaresi Esfeh, Kaveh Hajifathalian, Kianoush Ansari-Gilani
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2020-01-01
Series:Clinical and Molecular Hepatology
Subjects:
Online Access:http://e-cmh.org/upload/pdf/cmh-2019-0039.pdf
_version_ 1818142321530634240
author Jamak Modaresi Esfeh
Kaveh Hajifathalian
Kianoush Ansari-Gilani
author_facet Jamak Modaresi Esfeh
Kaveh Hajifathalian
Kianoush Ansari-Gilani
author_sort Jamak Modaresi Esfeh
collection DOAJ
description Background/Aims The American Association for the Study of Liver Diseases recommends ultrasound (US) screening for hepatocellular carcinoma (HCC) among cirrhotic patients, regardless of body mass index (BMI), every 6 months. We examined US sensitivity for diagnosis of HCC in obese patients. Methods Liver transplant patients data with HCC in explant was used (January 2012-December 2017). All patients underwent liver US within 3 months of diagnosis of HCC. Number/size of HCC lesions were extracted from radiologic and pathologic reports. Obesity was defined as BMI ≥30 kg/m2. Results One hundred sixteen patients were included. 80% were male, with mean BMI of 31 kg/m2. The most common underlying liver disease was hepatitis C virus (62%). At the time of diagnosis, median number of HCC lesions was 2 (interquartile range [IQR], 1–3), and median size of the largest lesion was 2.5 cm (IQR, 1.75–3.9). Overall sensitivity of US study for detection of HCC was 33% (95% confidence interval [CI], 29–48%). Sensitivity was 77% (95% CI, 62–93%) in patients with BMI<30 and 21% (95% CI, 11–30%) in patients with BMI≥30 (P<0.001). Size of the largest HCC lesion (P=0.290) and number of lesions (P=0.505) were not different between groups. Computed tomography (CT) scan detected HCC in 98% of the obese patients with negative US. Conclusions Sensitivity of US for detection of HCC is significantly lower among obese patients compared to overweight and normal weight patients. These patients may benefit from alternating between US and a different imaging modality.
first_indexed 2024-12-11T11:13:55Z
format Article
id doaj.art-badd271f972040909490e59fcac26cd9
institution Directory Open Access Journal
issn 2287-2728
2287-285X
language English
last_indexed 2024-12-11T11:13:55Z
publishDate 2020-01-01
publisher Korean Association for the Study of the Liver
record_format Article
series Clinical and Molecular Hepatology
spelling doaj.art-badd271f972040909490e59fcac26cd92022-12-22T01:09:25ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2020-01-01261545910.3350/cmh.2019.00391487Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standardJamak Modaresi Esfeh0Kaveh Hajifathalian1Kianoush Ansari-Gilani2 Department of Gastroenterology and Transplant Hepatology, Cleveland Clinic, Cleveland, OH, USA Department of Gastroenterology and Transplant Hepatology, Weill Cornell Medicine, New York, NY, USA Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, OH, USABackground/Aims The American Association for the Study of Liver Diseases recommends ultrasound (US) screening for hepatocellular carcinoma (HCC) among cirrhotic patients, regardless of body mass index (BMI), every 6 months. We examined US sensitivity for diagnosis of HCC in obese patients. Methods Liver transplant patients data with HCC in explant was used (January 2012-December 2017). All patients underwent liver US within 3 months of diagnosis of HCC. Number/size of HCC lesions were extracted from radiologic and pathologic reports. Obesity was defined as BMI ≥30 kg/m2. Results One hundred sixteen patients were included. 80% were male, with mean BMI of 31 kg/m2. The most common underlying liver disease was hepatitis C virus (62%). At the time of diagnosis, median number of HCC lesions was 2 (interquartile range [IQR], 1–3), and median size of the largest lesion was 2.5 cm (IQR, 1.75–3.9). Overall sensitivity of US study for detection of HCC was 33% (95% confidence interval [CI], 29–48%). Sensitivity was 77% (95% CI, 62–93%) in patients with BMI<30 and 21% (95% CI, 11–30%) in patients with BMI≥30 (P<0.001). Size of the largest HCC lesion (P=0.290) and number of lesions (P=0.505) were not different between groups. Computed tomography (CT) scan detected HCC in 98% of the obese patients with negative US. Conclusions Sensitivity of US for detection of HCC is significantly lower among obese patients compared to overweight and normal weight patients. These patients may benefit from alternating between US and a different imaging modality.http://e-cmh.org/upload/pdf/cmh-2019-0039.pdfliver cirrhosisneoplasmsobesity
spellingShingle Jamak Modaresi Esfeh
Kaveh Hajifathalian
Kianoush Ansari-Gilani
Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard
Clinical and Molecular Hepatology
liver cirrhosis
neoplasms
obesity
title Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard
title_full Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard
title_fullStr Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard
title_full_unstemmed Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard
title_short Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard
title_sort sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard
topic liver cirrhosis
neoplasms
obesity
url http://e-cmh.org/upload/pdf/cmh-2019-0039.pdf
work_keys_str_mv AT jamakmodaresiesfeh sensitivityofultrasoundindetectinghepatocellularcarcinomainobesepatientscomparedtoexplantpathologyasthegoldstandard
AT kavehhajifathalian sensitivityofultrasoundindetectinghepatocellularcarcinomainobesepatientscomparedtoexplantpathologyasthegoldstandard
AT kianoushansarigilani sensitivityofultrasoundindetectinghepatocellularcarcinomainobesepatientscomparedtoexplantpathologyasthegoldstandard